From: Application of biological age assessment of Chinese population in potential anti-ageing technology
Marker | Male (n = 584) mean ± SD | Female (n = 331) mean ± SD | P |
---|---|---|---|
ALT | 32.20 ± 18.49 | 23.91 ± 17.2 | < 0.001 |
AST | 21.58 ± 9.16 | 23.91 ± 17.2 | N.S. |
ALP | 69.55 ± 21.22 | 69.72 ± 22.87 | N.S. |
GGT | 43.96 ± 46.76 | 23.63 ± 19.65 | < 0.001 |
TP | 69.57 ± 4.65 | 69.63 ± 4.77 | N.S. |
ALB | 45.87 ± 3.20 | 44.97 ± 3.28 | < 0.001 |
GLB | 23.69 ± 3.76 | 24.66 ± 3.57 | < 0.001 |
TBIL | 12.99 ± 5.85 | 10.72 ± 4.11 | < 0.001 |
DBIL | 3.47 ± 1.82 | 2.64 ± 1.47 | < 0.001 |
IBIL | 9.52 ± 4.53 | 8.11 ± 3.14 | < 0.001 |
TBA | 9.22 ± 6.60 | 8.95 ± 6.61 | N.S. |
CHE | 9272.32 ± 1957.16 | 8728.16 ± 1961.14 | < 0.001 |
GLU | 7.27 ± 3.48 | 6.61 ± 3.02 | =0.003 |
CHOL | 5.05 ± 0.99 | 5.23 ± 1.05 | =0.010 |
TG | 3.04 ± 2.04 | 2.23 ± 1.83 | < 0.001 |
HDL | 1.17 ± 0.29 | 1.42 ± 0.34 | < 0.001 |
LDL | 2.92 ± 0.82 | 2.96 ± 0.81 | N.S. |
APOA | 1.25 ± 0.22 | 1.38 ± 0.25 | < 0.001 |
APOB | 0.97 ± 0.32 | 0.95 ± 0.29 | N.S. |
IGG | 11.5 ± 2.57 | 12.56 ± 2.77 | < 0.001 |
IGA | 2.43 ± 1.01 | 2.30 ± 0.98 | N.S. |
IGE | 139.45 ± 234.56 | 109.83 ± 179.50 | =0.033 |
IGM | 0.98 ± 0.58 | 1.35 ± 0.78 | < 0.001 |
UERA | 5.43 ± 1.34 | 4.97 ± 1.45 | < 0.001 |
CREA | 88.94 ± 20.42 | 77.25 ± 15.4 | < 0.001 |
UA | 410.48 ± 83.70 | 72.24 ± 15.40 | < 0.001 |
β2M | 0.99 ± 0.52 | 0.99 ± 0.51 | N.S. |
HCY | 12.62 ± 4.61 | 11.24 ± 4.16 | < 0.001 |
CYSC | 0.77 ± 0.28 | 0.73 ± 0.22 | N.S. |
LDH | 168.63 ± 29.33 | 177.86 ± 35.19 | < 0.001 |
CK | 157.18 ± 186.75 | 109.08 ± 58.44 | < 0.001 |
CKMB | 12.74 ± 4.90 | 11.71 ± 6.92 | =0.009 |
HBDH | 138.87 ± 25.96 | 150.37 ± 32.08 | < 0.001 |